1. Access to Medicine in Developing Countries: Elevating State Obligations Over Corporate Profit.
- Author
-
Yusuf, Hakeem O. and Omoteso, Kamil
- Subjects
Medical economics -- Analysis -- Ethical aspects -- Laws, regulations and rules ,Business ethics -- Management -- Analysis -- Laws, regulations and rules ,Corporate social responsibility -- Management -- Laws, regulations and rules -- Analysis ,Human rights -- Health aspects -- Demographic aspects -- Laws, regulations and rules ,Developing countries -- Health aspects -- Laws, regulations and rules ,Profitability -- Management -- Ethical aspects -- Laws, regulations and rules ,Government accountability -- Management -- Analysis -- Laws, regulations and rules ,Pharmaceutical industry -- Finance -- Laws, regulations and rules -- Ethical aspects ,Government regulation ,Company business management ,Company financing ,Agreement on Trade-Related Aspects of Intellectual Property Rights (art. 7) (art. 27) - Abstract
INTRODUCTION To ensure individual and social well-being, it is critical to bridge the gap between business and human rights on the accessibility of medicines through the combination of a human [...], This paper investigates the divergence between the objectives of the state in ensuring citizens' right to health and the profit-maximization objective of pharmaceutical corporations in relation to, access to, and supply of medicine. This divergence is pertinent given both the rising cost of medicines and unmet needs, particularly in developing countries. This paper analyses the correlation between pharmaceutical corporations' profit drive and the state's welfare obligation. There is a need to bridge the gap between business and human rights, which can be achieved by combining the concepts of ''business ethical responsibility" and corporations' contributions to "common good" with the jurisprudence on the right to health. This is imperative in view of the impact of the business of pharmaceutical corporations on vulnerable populations, particularly in, but not limited to, developing countries. Keywords: Human Rights, International Law, Pharmaceutical Companies, Business Ethics, Access to Medicines
- Published
- 2022